Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Experts’ Interviews

Home » Experts’ Interviews
  • Dr. Niels Van de Donk Interprets the Latest Research Progress on CAR-T Treatment for RRMM

    2023.10.12
  • Dr. Amir Fathi Interprets the Latest Developments in Targeted Therapy for Acute Myeloid Leukemia (AML)

    2023.10.12
  • SGBCC International Dialogue | Dr.Jia Wang & Dr.William Gradishar: Controversies in Surgical Treatment for Stage IV Breast Cancer Patients at Initial Diagnosis

    2023.10.12
  • Interview | Dr. Curigliano: New Thoughts on HER2-Positive Early Breast Cancer Treatment

    2023.10.12
  • Interview | Dr. Morrow: Thoughts on Breast Conservation and Reconstruction for Breast Cancer Patients

    2023.10.12
«previous
Recent Posts
  • Professor Wu Tong: Exploring the “Gaobo Model” of Hematopoietic Stem Cell Transplantation Strategies | 2026 Boren Hematologic Malignancies Precision Diagnosis and Treatment Conference
  • Professor Tong Chunrong: Entering a New Era of Integrated and Precision Diagnosis and Treatment in Hematologic Malignancies | 2026 Boren Precision Hematologic Oncology Conference
  • “PI Perspectives” S01E01 | Opening Episode: The HOPE Series Panorama — A Chinese Bladder-Preservation Strategy from Chemo-Immunotherapy to ADCs
  • PI Insights S01E02 | Where Are the Boundaries of Bladder Preservation? — The Clinical Rationale and Technical Foundation Behind the Expanded Enrollment Criteria of HOPE-02/03
  • PI Perspectives S01E03 | Finding Balance in the Chemo-Immunotherapy Era — A Strategic Dialogue Between HOPE-02, NIAGARA, RETAIN-02, and INDI-BLADE
Recent Comments
    Archives
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top